For laboratory research use only. Not for human or veterinary use.Lab research use only. Not for human or animal use.
Melanocortin-receptor agonist peptides — including PT-141 and Melanotan II — supplied as lyophilised powder for in vitro laboratory research. Every vial is independently HPLC-tested, certificate published in the COA library, stocked in Australia and dispatched the same business day when ordered before 12pm Sydney time. For in vitro research purposes only.
Melanocortin agonists are peptides that bind the melanocortin receptor family, MC1R through MC5R. This category groups PT-141, also called bremelanotide, which is used in melanocortin receptor pharmacology, and Melanotan II, an alpha-MSH analogue studied at the MC1R receptor. Australian Research Peptides lists both as freeze-dried powder, for in vitro laboratory research and no other purpose.
PT-141 is a cyclic heptapeptide, seven amino acids closed into a ring, Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH, and a non-selective melanocortin receptor agonist binding across MC1R to MC5R. It is studied in melanocortin receptor pharmacology and posted domestically to every state and territory. Laboratory material, never a medicine. In vitro research purposes only.
Studied in melanocortin receptor research, Melanotan II is a synthetic alpha-MSH analogue: seven amino acids ringed by a lactam bridge, freeze-dried in a sealed vial. The IUPHAR/BPS Guide to Pharmacology logs it as a full agonist at human MC1, MC3, MC4 and MC5 receptors, recording no MC2 interaction. In vitro research purposes only.
Choose by which melanocortin receptor the published work centres on. PT-141 is studied in receptor pharmacology broadly, while Melanotan II is an alpha-MSH analogue whose literature sits at MC1R. Both are supplied as a single 10 mg vial strength.
| Compound | Vial strengths listed | Studied in relation to |
|---|---|---|
| PT-141 | 10 mg | melanocortin receptor pharmacology |
| Melanotan II | 10 mg | melanocortin MC1 receptor research |